Pelvic mesh is a net-like synthetic medical implant designed to support weakened or damaged tissue in the pelvic floor, primarily used to treat pelvic organ prolapse and stress urinary incontinence in women. Pelvic mesh is also used in medical procedures such as hernia repair, pelvic organ prolapse, and urinary incontinence treatments. It is commonly used to treat pelvic floor disorders such as POP and SUI. When used as mesh for pelvic organ prolapse or stress urinary incontinence, the device provides additional support to pelvic tissues.
Since the FDA ordered manufacturers to stop selling transvaginal mesh for prolapse repair in 2019, many women are seeking clarity on what these devices are, their current regulatory status, and the serious complications that led to over 100,000 lawsuits against mesh manufacturers. The FDA continues to monitor the safety of transvaginal mesh devices in women who have already received them for pelvic organ prolapse repair. As of 2017, two types of urogynaecological mesh were no longer approved in Australia due to their associated risks.
Pelvic mesh complications include mesh erosion through the vaginal wall (occurring in 5-20% of transvaginal cases), chronic pain, dyspareunia, mesh migration, infection, and organ perforation—risks that prompted FDA restrictions on transvaginal mesh for POP repair while mesh slings for urinary incontinence remain available. The most common complications reported from pelvic mesh implants include chronic pain, recurrent urinary tract infections, and serious infections.
A systematic review of surgical mesh procedures for pelvic organ prolapse has evaluated the safety and effectiveness of these interventions, highlighting both benefits and potential risks.
Introduction to Pelvic Mesh
Pelvic mesh, often referred to as transvaginal mesh, is a specialized surgical mesh device used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in women. These conditions occur when the muscles and connective tissues supporting the pelvic organs—such as the bladder, uterus, and rectum—become weakened or damaged, often due to childbirth, aging, or other factors. As a result, pelvic organs may shift out of place, leading to symptoms like vaginal bulging, discomfort, and urinary incontinence.
To address these issues, surgeons may recommend mesh surgery, where a synthetic mesh—most commonly made from polypropylene—is implanted to reinforce the vaginal wall and provide lasting support to the affected organs. In transvaginal mesh surgery, the mesh is inserted through the vaginal wall to support prolapsed organs or to act as a sling beneath the urethra, helping to treat pelvic organ prolapse and alleviate symptoms of stress urinary incontinence. By supporting weakened or damaged tissue, pelvic mesh aims to restore normal anatomy and improve quality of life for women experiencing these challenging symptoms.
Understanding Pelvic Mesh Fundamentals
Pelvic mesh refers to a medical device made from synthetic material (most commonly polypropylene mesh) or biological tissue designed to reinforce weakened or damaged tissue in the pelvic region. The mesh functions by allowing the patient’s own tissue to grow into its macroporous structure, creating a reinforced barrier against organ descent.
These surgical mesh devices have been used in urogynecologic surgeries since the 1990s, evolving from their earlier application in abdominal hernia repairs dating back to the 1950s. Pelvic mesh is commonly utilized in prolapse surgery, where it helps support pelvic organs and treat pelvic organ prolapse (POP) and other pelvic floor disorders. The FDA provides detailed guidance on urogynecologic surgical mesh implants for both patients and healthcare providers.
Pelvic Organ Prolapse Treatment
Pelvic organ prolapse (POP) is a condition where weakened pelvic organs slip out of place, affecting many women, especially those who have given birth.
How is pelvic mesh used for pelvic organ prolapse? When pelvic organs such as the bladder, uterus, rectum, or vaginal walls descend due to weakened ligaments and muscles—a condition affecting nearly one-third of women—mesh is surgically implanted to support organs and reinforce the vaginal wall. Mesh is one of the surgical options used to treat POP, and is often considered when other methods to treat pop are not effective.
In POP surgery, mesh placement occurs through either transvaginal repair (an incision in the vaginal wall) or transabdominal approaches. The goal is to permanently bolster native tissue that may otherwise fail long-term, particularly for large cystoceles, lateral defects, or recurrent prolapse cases. For more information on this condition, the Mayo Clinic provides comprehensive information on pelvic organ prolapse symptoms and causes.
Stress Urinary Incontinence Management
Mesh slings represent a different application of surgical mesh, designed to treat stress urinary incontinence by cradling the urethra during physical stress activities like coughing, sneezing, or exercising. Unlike prolapse mesh that supports larger organ structures, these sling devices specifically target lower urinary tract symptoms.
Midurethral sling procedures have demonstrated effectiveness rates that have kept them available even after FDA restrictions on transvaginal mesh for prolapse. The Cleveland Clinic offers detailed information on stress urinary incontinence and available treatments.
Understanding the distinction between mesh for POP repair (now restricted) and mesh slings for urinary incontinence (still available) is essential for patients navigating their surgical options.
Four Types of Surgical Mesh Implants
What are the four types of surgical mesh implants? Surgical mesh devices in urogynecology are classified by material composition and placement method, with each type presenting distinct risk profiles and applications.
Polypropylene Synthetic Mesh
Synthetic mesh made from polypropylene represents the most common type used in pelvic surgeries. Type 1 monofilament macroporous polypropylene mesh is specifically prized for its lower infection and erosion risk compared to multifilament varieties.
This synthetic material provides permanent support but cannot be absorbed by the body, meaning it remains indefinitely once implanted. While durability benefits include long-term structural support, the permanence also contributes to complication risks when adverse events occur.
Biological Mesh
Biological mesh is derived from animal tissue (typically porcine or bovine sources) or human donor tissue. Unlike synthetic alternatives, biological meshes are absorbable and integrate differently with the patient’s native tissue.
These mesh devices may present lower erosion rates but typically offer less long-term structural support as they gradually absorb. They are sometimes considered for complex cases or patients with high risk factors for synthetic mesh complications.
Transvaginal Mesh
Transvaginal mesh involves placement through a vaginal incision for prolapse repair. This surgical procedure uses trocar-guided insertion through the vaginal wall, positioning mesh to support organs that have descended. Transvaginal mesh is also commonly referred to as vaginal mesh, especially in the context of procedures for pelvic organ prolapse and stress urinary incontinence.
The FDA ordered mesh manufacturers to stop distributing transvaginal mesh for POP repair in 2019 due to insufficient evidence that benefits outweigh risks compared to native tissue repair. This represents the mesh type most associated with serious adverse events. Common complications associated with transvaginal mesh include bleeding, pain, inflammation, and infections.
Transabdominal Mesh
Transabdominal mesh placement uses small abdominal incisions for procedures like sacral colpopexy, positioning mesh to support apical prolapse through laparoscopic procedures or robotic surgery. The American College of Obstetricians and Gynecologists provides guidelines on surgery for pelvic organ prolapse, including transabdominal approaches.
This method has over 30 years of safety data and was not subject to FDA bans. Transabdominal approaches carry lower erosion incidence because mesh avoids direct vaginal exposure, making them the current gold standard for apical prolapse repair.
What are Pelvic Mesh Complications and Disadvantages?
What are the complications of pelvic mesh? What are the disadvantages of pelvic mesh implants? The FDA has documented extensive risks unique to urogynecologic mesh use, with transvaginal approaches carrying 2-3 times more adverse events reported compared to abdominal methods.
Multicenter trials have shown that while mesh-augmented repairs achieve superior objective outcomes (such as POPQ stage 0-1 at 12 months), they also produce doubled adverse event rates compared to native tissue repair. A peer-reviewed clinical study on transvaginal mesh complications published in PubMed documents these findings in detail.
Mesh Erosion and Exposure
Mesh erosion represents the most common complication, occurring when synthetic mesh breaks through the vaginal wall or other tissues. Studies report erosion rates of 5-20% in transvaginal POP repairs, with some early research documenting rates as high as 30%.
Symptoms of mesh erosion include:
- Vaginal bleeding or discharge
- Pain during intercourse (dyspareunia affecting up to 22% of patients)
- Visible or palpable mesh in the vagina
- Partner discomfort during intimacy
Treatment for erosion typically requires surgical removal of exposed mesh sections, sometimes necessitating repeat surgery or complete mesh explantation.
Mesh Migration and Contraction
Mesh contraction occurs when the implanted material shrinks or contracts within the body, potentially causing organ displacement and chronic pain. This shrinkage can pull tissues out of normal anatomical position, creating new symptoms while failing to resolve the original prolapse.
Mesh migration refers to the device moving from its original placement location over time. Both conditions can result in recurrent prolapse, negating the surgical procedure’s intended benefits while introducing new complications.
Organ Perforation
Organ perforation represents one of the most serious complications, occurring when mesh penetrates the bladder, bowel, or other pelvic structures. This can happen during initial mesh placement or as a delayed complication from mesh migration.
Emergency symptoms requiring immediate medical attention include:
- Severe pelvic pain
- Blood in urine or stool
- Bowel symptoms including difficulty with bowel movements
- Signs of infection such as fever
Chronic Pain and Sexual Dysfunction
Many women experience persistent pelvic pain that significantly affects daily activities, with some cohorts reporting chronic pain in 10-62% of patients. This pain may manifest as constant discomfort or intermittent sharp sensations in the pelvic region, buttocks, or legs.
Sexual dysfunction includes dyspareunia (painful intercourse), vaginal scarring, and shortened vaginal length. These complications can profoundly impact intimate relationships and quality of life, with some patients reporting complete inability to engage in sexual activity.
Pelvic Mesh Removal Surgery Options and Complications
Which are pelvic mesh removal surgery options and complications? When complications like erosion, chronic pain, or infection become intractable, mesh removal surgery becomes necessary—though it presents significant challenges and risks of its own.
Mesh removal is considerably more complex than initial placement because tissue has typically grown into the mesh structure. Complete removal requires specialized training, and outcomes vary significantly based on surgeon experience and the extent of tissue integration.
Partial Mesh Removal
Partial mesh removal involves excision of exposed or problematic mesh sections while leaving incorporated portions in place. This approach may be appropriate when:
- Only a localized section has eroded
- Complete removal presents excessive surgical risks
- The remaining mesh continues providing structural support
Success rates for partial removal vary, and patients must understand that remaining mesh may continue causing symptoms or require additional surgery later.
Complete Mesh Removal
Complete mesh explantation aims to remove all implanted mesh material. Surgical approaches include:
- Transvaginal removal for mesh accessible through the vagina
- Transabdominal or laparoscopic procedures for intraabdominal portions
- Combined approaches for complex cases requiring both access routes
Complete removal achieves symptom relief in 60-80% of patients but carries significant risks including further organ damage and incomplete removal where microscopic mesh fragments remain embedded in tissue.
Revision Surgery Complications
Repeat surgery introduces additional risks beyond the original procedure:
- Increased infection risk from repeat surgical trauma
- Worsened prolapse occurring in 15-30% of cases after mesh removal
- Persistent pain affecting 20-40% of patients
- Vaginal shortening in up to 20% of cases
- Fistula formation between organs
- Bleeding and anesthesia complications
Recovery timelines extend significantly for revision surgeries, and patients may require ongoing management for recurrent prolapse or continued symptoms. Only experienced surgeons in multidisciplinary settings typically achieve optimal outcomes for these challenging procedures.
Alternative Treatments and Current Recommendations
Following FDA restrictions and growing awareness of mesh complications, current medical guidelines emphasize patient safety through careful evaluation of non-surgical treatment options and surgical alternatives before considering mesh implantation.
Native Tissue Repair
Native tissue repair uses the patient’s own tissue to correct prolapse without synthetic material. This traditional colporrhaphy approach relies on stitches to ligaments and fascial tissue to support organs.
While historical native tissue repairs showed higher recurrence rates (50%+ in some high-risk cases versus 33% with mesh), they avoid the serious complications associated with synthetic material. Current guidelines from ACOG suggest native tissue repair as the first-line surgical treatment for many women, particularly those with primary or small defects.
Pessary Devices
Pessaries are removable silicone devices inserted into the vagina to support organs without surgery. These represent a legitimate long-term treatment option rather than merely a temporary measure.
Key considerations for pessary use include:
- Professional fitting to determine appropriate size and type
- Regular maintenance including removal for cleaning
- Periodic examinations to check for vaginal irritation
- Suitability for women preferring to avoid surgery or those with high surgical risk
Pelvic Floor Therapy
Pelvic floor physical therapy serves as first-line treatment for mild to moderate prolapse and stress urinary incontinence. Supervised exercises strengthen the muscles supporting pelvic structures, potentially reducing or eliminating symptoms without surgical intervention.
This conservative approach carries no surgical risks and may be combined with pessary use or other treatments. For many women, pelvic floor therapy provides sufficient symptom relief to avoid surgical management entirely.
Making Informed Treatment Decisions
Current FDA recommendations maintain restrictions on transvaginal mesh for POP repair while allowing mesh slings for stress urinary incontinence and transabdominal mesh for prolapse. Medical consensus from organizations including ACOG emphasizes thorough informed consent and consideration of alternatives before any mesh procedure.
Key questions to ask healthcare providers:
- What is my specific diagnosis and its severity?
- What non-mesh alternatives would address my condition?
- What is your experience with the recommended procedure?
- What are the specific complication rates at your facility?
- What would happen if I develop mesh complications?
Steps for obtaining appropriate care:
- Request a second opinion from a urogynecologist or pelvic floor specialist
- Ask about your surgeon’s training and case volume for the recommended procedure
- Review all treatment options including conservative management
- Ensure you receive complete informed consent documentation
- Understand your options if complications develop
Who needs pelvic mesh devices, and how are they used?
Transvaginal mesh is used to treat pelvic organ prolapse (POP) and also treat stress urinary incontinence in women (SUI). If you are a woman suffering from one of these problems, the surgical mesh will almost certainly be utilized to treat the issue if more conservative treatments fail.
The following are the only non-surgical treatment options:
· Pessaries (tiny silicone or plastic implants used to keep organs in place)
· Pelvic floor exercises
· Surgery without mesh (in which the surgeon uses the patient’s own tissue as support)
However, the surgical mesh has remained doctors’ first choice. In Pelvic organ prolapse instances, it is permanently implanted to strengthen the fragile vaginal wall. In terms of Stress urinary incontinence repair, it acts as a sling to support the urethra or bladder neck.
What is stress urinary incontinence, and how is pelvic mesh used to treat it?
Stress urinary incontinence occurs when the bladder leaks urine due to increased pressure caused by physical exercise.
This affects up to 20% of women, especially after delivery or menopause. When the pelvic muscles are weakened, transvaginal mesh supports the urethra. There are no symptoms other than unintended pee leaking when patients cough, sneeze, have sex, laugh, stand up, or do anything that puts pressure on the bladder. This is uncomfortable and humiliating for women.
However, mesh surgery may be able to assist. Mesh slings can be implanted through a vaginal incision by surgeons. They can also do the procedure through two tiny incisions in the lower stomach, slightly above the pubic bone. The urethra, or tube that transports pee from the body, is supported by the mesh sling. This surgery is known as a mesh sling or a mid-urethral sling.
What is pelvic organ prolapse, and what is pelvic organ prolapse repair?
Pelvic organ prolapse is typically accompanied by pain and discomfort when moving. However, in other cases, the patient may have no symptoms.
Pelvic mesh is implanted to support the region when pelvic organs droop or fall into the vaginal canal due to weak pelvic muscles. The rectum, colon, bladder, or uterus are the most frequent organs affected by prolapse, with the bladder being the most common.
Surgical mesh devices can be surgically implanted on the vaginal front, top, or rear wall to give support. The mesh works as a sling (sometimes known as a “bladder sling” when used in this context), supporting drooping organs.
Many women who have undergone transvaginal mesh surgery to repair pelvic organ prolapse and stress urinary incontinence treatment are filing transvaginal mesh lawsuits due to mesh complications. The implant has been proven to be no more successful than other options, yet it causes severe issues for many people.
Women currently experiencing mesh complications should seek care from specialists experienced in mesh removal and revision surgery. Support resources including patient advocacy groups and legal resources exist for those who have experienced serious adverse events from surgical mesh devices.
The future of pelvic floor treatment may include bioengineered absorbable meshes or regenerative therapies designed to avoid the pitfalls of permanent synthetic implants. Until such innovations prove safe and effective, careful patient selection, thorough informed consent, and consideration of alternatives remain essential to protecting patients undergoing treatment for pelvic floor disorders.
Conclusion
Pelvic mesh has played a significant role in the surgical management of pelvic floor disorders, offering a treatment option for women with pelvic organ prolapse and stress urinary incontinence when other therapies have not provided relief. While surgical mesh devices—especially transvaginal mesh—have helped many women regain function and comfort, they have also been associated with serious complications such as mesh erosion, chronic pain, infection, and the need for repeat surgery. As a result, regulatory agencies and medical organizations now emphasize the importance of patient safety, thorough informed consent, and careful patient selection.
For women considering treatment for pelvic floor disorders, it is essential to understand all available options, including non surgical treatment options like pessaries and pelvic floor therapy, as well as native tissue repair and other surgical treatments. Consulting with experienced specialists, asking detailed questions about risks and benefits, and staying informed about the latest developments in mesh technology and alternative therapies can help ensure the best possible outcomes.
As research continues and new materials and techniques emerge, the future of prolapse and incontinence treatment may offer safer, more effective solutions. Until then, making informed decisions and prioritizing patient safety remain at the heart of managing pelvic organ prolapse and stress urinary incontinence.
